Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 15 | 19 | 26 | 32 | 38 |
| Gross Profit | 15 | 19 | 26 | 32 | 38 |
| Operating Expenses | 625 | 481 | 845 | 2,188 | 1,857 |
| Operating Income | -610 | -462 | -819 | -2,156 | -1,819 |
| Interest Expense | 43 | 24 | 286 | 428 | 395 |
| Other Income | -183 | 3,362 | -6,446 | 1,034 | -2,843 |
| Pre-tax Income | -836 | 2,876 | -7,551 | -1,551 | -5,057 |
| Net Income Continuous | -836 | 2,876 | -7,551 | -1,551 | -5,057 |
| Net Income | $-836 | $2,876 | $-7,551 | $-1,551 | $-5,057 |
| EPS Basic Total Ops | -2.10 | 0.00 | -33.33 | 300.00 | -766.67 |
| EPS Basic Continuous Ops | -2.10 | 6.01 | -26.22 | 331.51 | -783.30 |
| EPS Diluted Total Ops | -2.10 | 0.00 | -33.33 | 300.00 | -766.67 |
| EPS Diluted Continuous Ops | -2.10 | 6.01 | -26.22 | 331.51 | -783.30 |
| EBITDA(a) | $-585 | $-435 | $291 | $-1,651 | $-276 |